Cargando…
Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership
OBJECTIVES: This study establishes research priorities for medically not yet explained symptoms (MNYES), also known as persistent physical symptoms or medically unexplained symptoms, from the perspective of patients, caregivers and clinicians, in a priority setting partnership (PSP) following the Ja...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252198/ https://www.ncbi.nlm.nih.gov/pubmed/35777869 http://dx.doi.org/10.1136/bmjopen-2022-061263 |
_version_ | 1784740211925712896 |
---|---|
author | van der Feltz-Cornelis, Christina Maria Sweetman, Jennifer Edwards, Mark Gall, Nicholas Gilligan, Jennifer Hayle, Stephanie Kaul, Arvind Moriarty, Andrew Stephen Perros, Petros Sampford, James Smith, Natalie Elfeddali, Iman Varley, Danielle Gower, Jonathan |
author_facet | van der Feltz-Cornelis, Christina Maria Sweetman, Jennifer Edwards, Mark Gall, Nicholas Gilligan, Jennifer Hayle, Stephanie Kaul, Arvind Moriarty, Andrew Stephen Perros, Petros Sampford, James Smith, Natalie Elfeddali, Iman Varley, Danielle Gower, Jonathan |
author_sort | van der Feltz-Cornelis, Christina Maria |
collection | PubMed |
description | OBJECTIVES: This study establishes research priorities for medically not yet explained symptoms (MNYES), also known as persistent physical symptoms or medically unexplained symptoms, from the perspective of patients, caregivers and clinicians, in a priority setting partnership (PSP) following the James Lind Alliance (JLA) approach. Research into such symptoms in general has been poorly funded over the years and so far has been primarily researcher-led with minimal input from patients, caregivers and clinicians; and sometimes has been controversial. DESIGN: JLA PSP method. The PSP termed these symptoms MNYES. METHODS: The study was conducted according to the JLA’s detailed methodology for conducting priority setting exercises. It involved five key stages: defining the appropriate term for the conditions under study by the PSP Steering Group; gathering questions on MNYES from patients, caregivers and clinicians in a publicly accessible survey; checking these research questions against existing evidence; interim prioritisation in a second survey; and a final multi-stakeholder consensus meeting to determine the top 10 unanswered research questions using the modified nominal group methodology. RESULTS: Over 700 responses from UK patients, caregivers and clinicians were identified in the two surveys and charities contributed from a broad range of medical specialties and primary care. The final top 10 unanswered research questions cover, among others: treatment strategies, personalisation of treatment, collaborative care pathways, training for clinicians and outcomes that matter to patients. INTERPRETATION: The top 10 unanswered research questions are expected to generate much needed, relevant and impactful research into MNYES. |
format | Online Article Text |
id | pubmed-9252198 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-92521982022-07-05 Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership van der Feltz-Cornelis, Christina Maria Sweetman, Jennifer Edwards, Mark Gall, Nicholas Gilligan, Jennifer Hayle, Stephanie Kaul, Arvind Moriarty, Andrew Stephen Perros, Petros Sampford, James Smith, Natalie Elfeddali, Iman Varley, Danielle Gower, Jonathan BMJ Open Evidence Based Practice OBJECTIVES: This study establishes research priorities for medically not yet explained symptoms (MNYES), also known as persistent physical symptoms or medically unexplained symptoms, from the perspective of patients, caregivers and clinicians, in a priority setting partnership (PSP) following the James Lind Alliance (JLA) approach. Research into such symptoms in general has been poorly funded over the years and so far has been primarily researcher-led with minimal input from patients, caregivers and clinicians; and sometimes has been controversial. DESIGN: JLA PSP method. The PSP termed these symptoms MNYES. METHODS: The study was conducted according to the JLA’s detailed methodology for conducting priority setting exercises. It involved five key stages: defining the appropriate term for the conditions under study by the PSP Steering Group; gathering questions on MNYES from patients, caregivers and clinicians in a publicly accessible survey; checking these research questions against existing evidence; interim prioritisation in a second survey; and a final multi-stakeholder consensus meeting to determine the top 10 unanswered research questions using the modified nominal group methodology. RESULTS: Over 700 responses from UK patients, caregivers and clinicians were identified in the two surveys and charities contributed from a broad range of medical specialties and primary care. The final top 10 unanswered research questions cover, among others: treatment strategies, personalisation of treatment, collaborative care pathways, training for clinicians and outcomes that matter to patients. INTERPRETATION: The top 10 unanswered research questions are expected to generate much needed, relevant and impactful research into MNYES. BMJ Publishing Group 2022-07-01 /pmc/articles/PMC9252198/ /pubmed/35777869 http://dx.doi.org/10.1136/bmjopen-2022-061263 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Evidence Based Practice van der Feltz-Cornelis, Christina Maria Sweetman, Jennifer Edwards, Mark Gall, Nicholas Gilligan, Jennifer Hayle, Stephanie Kaul, Arvind Moriarty, Andrew Stephen Perros, Petros Sampford, James Smith, Natalie Elfeddali, Iman Varley, Danielle Gower, Jonathan Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership |
title | Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership |
title_full | Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership |
title_fullStr | Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership |
title_full_unstemmed | Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership |
title_short | Identifying the top research priorities in medically not yet explained symptoms (MNYES): a James Lind Alliance priority setting partnership |
title_sort | identifying the top research priorities in medically not yet explained symptoms (mnyes): a james lind alliance priority setting partnership |
topic | Evidence Based Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252198/ https://www.ncbi.nlm.nih.gov/pubmed/35777869 http://dx.doi.org/10.1136/bmjopen-2022-061263 |
work_keys_str_mv | AT vanderfeltzcornelischristinamaria identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership AT sweetmanjennifer identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership AT edwardsmark identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership AT gallnicholas identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership AT gilliganjennifer identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership AT haylestephanie identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership AT kaularvind identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership AT moriartyandrewstephen identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership AT perrospetros identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership AT sampfordjames identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership AT smithnatalie identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership AT elfeddaliiman identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership AT varleydanielle identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership AT gowerjonathan identifyingthetopresearchprioritiesinmedicallynotyetexplainedsymptomsmnyesajameslindallianceprioritysettingpartnership |